¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Center for Disease Control and Prevention"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûº´, ´ç¿øÃàÀûº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • Greenfield¡¯s disease
    ±×¸°Çʵ庴
  • Hartnup¡¯s disease
    ÇÏÆ®³Òº´
  • Hashimoto¡¯s disease
    ÇϽøðÅ亴
  • hyperendemic disease
    °ú´ÙºóµµÇ³Å亴, °ú´ÙÁö¹æÀ¯Çິ
  • hypertensive disease
    °íÇ÷¾Ðº´
  • hypertensive heart disease
    °íÇ÷¾Ð½ÉÀ庴, °íÇ÷¾Ð½ÉÀåÁúȯ
  • hypertensive vascular disease
    °íÇ÷¾ÐÇ÷°üº´
  • heart disease
    ½ÉÀ庴
  • heart muscle disease
    ½ÉÀå±ÙÀ°º´, ½É±ÙÁúȯ
  • heavy-chain disease
    ¹«°Å¿î»ç½½º´, Á߼⺴
  • hemoglobin C disease
    Çì¸ð±Û·ÎºóCº´
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • exotic disease
    ¿Ü·¡º´
  • extraarticular rheumatic disease
    °üÀý¿Ü·ù¸¶Æ¼½ºº´
  • extrapyramidal disease
    Ãßü¿Ü·Îº´
  • fat deficiency disease
    Áö¹æ°áÇÌÁõ
  • febrile disease
    ¿­º´
  • fibrocystic disease
    ¼¶À¯³¶º´
  • fibromuscular disease
    ¼¶À¯±ÙÀ°º´
  • fifth disease
    (¢¡erythema infectiosum) °¨¿°È«¹Ý
  • fishskin disease
    (¢¡ichthyosis) ºñ´ÃÁõ
  • fluke disease
    ÈíÃæº´
  • foot process disease
    ¹ßµ¹±âº´
  • functional cardiovascular disease
    ±â´É½ÉÀåÇ÷°üº´
  • fungal disease
    Áø±Õº´, Áø±ÕÁúȯ, °õÆÎÀ̺´
  • gamma chain disease
    °¨¸¶°í¸®º´
  • gastroesophageal reflux disease
    À§½Äµµ¿ª·ùº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • Parkinsons disease
    ÆÄŲ½¼º´
  • Parkinsons disease
    ÆÄŲ½¼º´.
  • Pick s disease
    ÇȺ´.
  • Picks disease
    ÇÇÅ©º´(~Ü»)
  • Pompe disease
    ÆûÆäº´
  • Pompes disease
    ÆûÆä¾¾ º´
  • Pott s disease
    Æ÷Æ®º´ ôÃßÄ«¸®¿¡½º .
  • Potts disease
    Æ÷Æ®º´, ôÃßÄ«¸®¿¡½º .
  • Pseudo Hurler disease
    °¡¼ºÇæ·¯º´
  • Raynaud s disease
    ·¹À̳뺴.
  • Refsum s disease
    ·¹ÇÁ¼ûº´.
  • Refsums disease
    ·¹ÇÁ¼û º´
  • Ritter disease
    ¸®ÅÍ º´
  • Rombergs disease = Romberg syndrome
    ·Òº£¸£Å©º´
  • Schilder s disease
    ½Ç´õº´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • satiety center
    Æ÷¸¸ÁßÃß(¡­ñéõÒ), ¸¸º¹ÁßÃß(Ø»ÜÙñéõÒ).
  • secondary ossification center
    ÀÌÂ÷°ñÈ­Áß½É(¡­Íéûùñéãý).
  • secondary ossification center
    ÀÌÂ÷»À¹ß»ýÁß½É
  • secondary ossification center [epiphyseal ossification cente
    ÀÌÂ÷»À¹ß»ýÁ᫐ (»À³¡»À¹ß»ýÁß½É
  • sense center
    Áö°¢ÁßÃß.
  • sleeping center
    ¼ö¸éÁßÃß.
  • speech center
    ¾ð¾îÁßÃß(¡­ñéõÒ).
  • speech center, acoustic
    û°¢(¼º) ¾ð¾îÁßÃß
  • spinal cardioaccelerator center
    ô¼ö½ÉÀåÃËÁøÁßÃß(¡­ãýíôõµòäñéõÒ).
  • superordinate center
    »óÀ§Ãß(ß¾êÈõÒ).
  • swallowing center
    ¿¬ÇÏÁßÃß(æ¿ù»ñéõÒ).
  • swallowing center
    ¿¬ÇÏÁßÃß(æ¿ù»ñéõÒ)
  • sweating center
    ¹ßÇÑÁßÃß.
  • sweating center
    ¹ßÇÑÁßÃß
  • temperature regulatory center
    ü¿ÂÁ¶ÀýÁß¼Ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
CCDC Canadian Communicable Disease Center
CSCD Center for Sickle Cell Disease
IHD in-center hemodialysis; ischemic heart disease
KDC kidney disease treatment center
NHDC National Hansen's Disease Center
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
CG 2--Control
ICR 3'-internal control region
RCE 3'-retinoblastoma control element
ABCD Appropriate Blood Pressure Control in Diabetes
A/C Assist/Control
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Hailey-Hailey disease
    ÇìÀϸ® ÇìÀϸ® º´
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â. °æºÎ, ¾×¿Í, ¼­ÇýºÎ¿¡ ÀÛÀº ¼öÆ÷ ¹× Å« ¼öÆ÷°¡ ¹Ýº¹ÇÏ¿© ¹ß»ýÇÏ´Â Èñ±ÍÇÑ À¯Àü¼º Áúȯ. »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏ¸ç ºÒ¿ÏÀüÇÑ Ç¥ÇöÀ²À» °¡Áø´Ù. ¸ð³¶ °¢È­Áõ°ú À¯»çÇÏ°Ô »ý°¢ÇÏ¸ç ºÎÂø ¹Ý³» ¼¼Æ÷°£ Á¢ÃËÃþÀÇ ¼Ò½Ç ¶Ç´Â ´ç±è¼¼»çÀÇ °áÇÔÀ» µé°í ÀÖ´Ù.
  • Hand Schuller Christian disease
    ÇÑÆ® ½¶·¯ Å©¸®½ºÂù º´, ÇÚµå ½¶·¯ Å©¸®½ºÂù º´, Hand-Schuller-Christian º´
    1. ´Ù¼Ò¼º È£»ê¼º À°¾ÆÁ¾ÀÌ 5¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ´Â °æ¿ì¿¡ »ç¿ëÇÏ´Â ¿ë¾î. ¹ß¿­, Àü½Å¼º Àμ³, µÎÇÇ¿Í À̰ü ÇǺÎÀÇ Áö·ç¼º ¹ßÁø, ÁßÀÌ¿°, À¯¾çµ¹±â¿° ¹× Ä¡Àº¿°°ú »ó±âµµ ¿°ÁõÀ» ÈçÈ÷ µ¿¹ÝÇÑ´Ù. 2. °æµµÀÇ ¸²ÇÁÀý Á¾´ë, °£ºñ Á¾´ë°¡ ÃÊ·¡µÉ ¼ö ÀÖ°í ÆóÀå³»¿¡ À°¾ÆÁ¾ Çü¼º ¶Ç´Â °£ÇæÀûÀÎ ¹Ì»ý¹° °¨¿°¿¡ ÀÇÇÑ °ÍÀ¸·Î º¸ÀÌ´Â ¹Ì¸¸¼º Æó¿° ¼Ò°ßÀ» º¼ ¼ö ÀÖ´Ù. 3. ¾î¸°ÀÌ ¹× 10´ë Ãʹݿ¡ ¹ßº´Çϸç 3´ë Áõ»óÀ¸·Î´Â ¾È±¸ µ¹ÃâÁõ, °ñ º´¼Ò, ´¢ºØÁõ
  • Hand-Schuller-Christian disease
    ÇÚµå-½¯·¯-Å©¸®½ºÂù º´
  • Hansen's disease
    ÇѼ¾º´, ³ªº´
    ÁÖ·Î ÇÇºÎ¿Í ¸»ÃʽŰæÀ» ħ¹üÇÏ´Â ¸¸¼º À°¾ÆÁ¾¼º °¨¿°ÀÇ ÀÏÁ¾. Mycobacterium le
  • Hartnup disease
    Çϸ£Æ®´©ÇÁ º´
    À¯Àü¼º
  • Hashimoto's disease
    ÇϽø𵵠º´
    °©»ó¼±ÀÇ ÁøÇ༺ ÀÚ°¡ ¸é¿ª ÁúȯÀ¸·Î¼­ ¸²ÇÁ±¸ ħÀ±°ú ¼øÈ¯Áß ÀÚ°¡ Ç×ü¸¦ µ¿¹ÝÇÑ´Ù. ¿©ÀÚ¿¡°Ô Àß ÀϾ°í °¡°èÀû ¼ÒÀÎ °æÇâÀÌ ÀÖ´Ù. ¶§·Î´Â °©»ó¼± ±â´É Ç×ÁøÁõ¿¡ ÈļÓÇÏ¿© ³ªÅ¸³ª¸ç, ȯÀÚ´Â °©»ó¼± Á¾´ë¸¦ ÀÏÀ¸Å°°í Á¡ÁøÀûÀ¸·Î °©»ó¼± ±â´É ÀúÇÏ »óÅ¿¡ ºüÁø´Ù.
  • heart disease
    ½ÉÀå º´, ½É Áúȯ
    ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ Áúȯ. ÀϹÝÀûÀ¸·Î °ü Ç÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´º¯ÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÌ·ç¾îÁö°í ÀÖ´Ù. ÀüÀÚ´Â ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼­ º»ÁúÀûÀÎ ¿øÀÎ ¿ä¹ýÀÌ °¡´ÉÇÏ°Ô µÈ ÀÌÈÄ´Â ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ À־ ¸¹ÀÌ ¾²ÀÌ°Ô µÇ¾ú´Ù. º´º¯ ºÎÀ§·Î´Â ½É³»¸·
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
  • hematologic disease
    Ç÷¾× Áúȯ
  • hematopoietic disease
    Á¶Ç÷ Áúȯ, Á¶Ç÷¼º Áúȯ
    Ç÷°üÀ̳ª Ç÷¾× ¼ººÐÀ» »ý¼ºÇÏ´Â µ¥ ÀÖ¾î ¹®Á¦¸¦ ÀÏÀ¸Å°´Â Áúº´.
  • hemic disease
    Ç÷¾× Áúȯ
  • hemolytic disease
    ¿ëÇ÷¼º Áúȯ
  • hepatocerebral disease
    °£ ³ú ÁõÈıº
    Àª½¼ º´°ú À̳뼼ÇüÀ¸·Î Å©°Ô ³ª´­ ¼ö ÀÖ´Ù. Àª½¼ º´Àº ¼±Ãµ¼ºÀÎ °áÇÔÀ¸·Î ÀÎÇÑ ±¸¸® ´ë»ç ÀÌ»óÀ¸·Î¼­, °£ ¹× ³ú¿¡ ´Ù·®ÀÇ ±¸¸®°¡ Ä§ÂøÇÑ´Ù. °£Àº ÇöÀúÇÑ °æº¯ÁõÀ» ³ªÅ¸³»°í, °£ ±â°£ºÎÀÇ ·»Áî ÇÙÀ̳ª Çǰ¢ µî¿¡ º¯¼ºÀÌ »ý±ä´Ù. ÇÇ, ¿ÀÁÜ ¼ÓÀÇ ±¸¸®´Â ºÒ¾î³ª³ª, Ç÷¾× ¼ÓÀÇ ±¸¸® °áÇÕ ´Ü¹éÁúÀÎ ¼¿·ê·Î Çö󽺹ÎÀº °¨¼ÒÇÏ°í °¢¸·¿¡ Ä«ÀÌÀú ÇöóÀ̼ŠȯÀÌ »ý±ä´Ù. À̳뼼Çü Áß °£ ¿ÜÇüÀº °£ Áúȯ ½Ã¿¡ °£ ³» Ç÷·ù°¡ °ï¶õÇÏ°Ô µÈ °á°ú, °£ ¿ÜÀÇ ´Ü¶ôÀ» ÅëÇÏ¿© ³»¸ÆÇ÷ÀÌ ±×´ë·Î ½ºÃÄ Áö³ª°¡±â ¶§¹®¿¡ Ç÷¾× ¼ÓÀÇ ¾Ï¸ð´Ï¾Æ °ªÀÌ »ó½ÂÇÏ¿© ³ú Áõ»óÀ» ÀÏÀ¸Å²´Ù. °£³»ÇüÀº ÁÖ·Î Áö¹æ¼º °£ °æº¯Áõ µî¿¡¼­ °£ ³»ÀÇ ´Ü¶ôÀ» ±×´ë·Î ºüÁ®³ª°¡±â ¶§¹®¿¡ À§¿Í °°Àº °á°ú¸¦ °¡Á®¿À´Â °ÍÀ» ¸»ÇÑ´Ù.
  • hereditary disease
    À¯Àüº´
    À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ½ÅüÀû, Á¤½ÅÀûÀÎ ÀÌ»óÀÇ ÃÑĪ. À¯Àü¼º ÁúȯÀ̶ó°íµµ ÇÑ´Ù. º´, ÀÌ»ó ÇüÁúÀÌ À¯ÀüÀû ¿äÀΰú °ü·ÃÀÌ ÀÖÀ½¿¡ µû¶ó¼­ ¹Ýµå½Ã À¯ÀüÀÚ¿¡ ÀÇÇÏÁö ¾Ê´Â À¯ÀüÀûÀÎ º´µµ À¯Àüº´À̶ó°í ÇÏ°Ô µÇ¾ú´Ù. 1°³ÀÇ ¿ì¼º À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ÇåÆÃÅÏ ¹«µµº´, ¹ß·»ºÎ¸£Å© ÁõÈıº, ¿­¼º À¯ÀüÀÚÀÇ µ¿Çü Á¢ÇÕ¿¡ ÀÇÇÏ¿© ³ªÅ¸³ª´Â ¹éÀÚ, Æä´ÒÄÉÅæ´¢Áõ, X ¿°»öü À§ÀÇ ¹Ý¼º À¯ÀüÀÚ¿¡ ÀÇÇÑ Àû·Ï »ö¸Í, Ç÷¿ìº´, ÁøÇ༺ ±Ù µð½ºÆ®·ÎÇÇÁõ µîÀº ¸í¹éÈ÷ ÀÌÀ¯ ÀüÀÚ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼­, À¯Àüº´ÀÇ ´ëÇ¥ÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ¹Ý¼º À¯ÀüÀÚ´Â X ¿°»öü À§¿¡ À§Ä¡ÇÏ´Â °Í¸¸ ¾Ë·ÁÁ® ÀÖ°í, ³²¼ºÀ» °áÁ¤ÇÏ´Â Y ¿°»öü À§¿¡´Â ÇöÀç±îÁö ƯÈ÷ È®½ÇÇÑ ÇüÁúÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚ´Â Á¸ÀçÇÏÁö ¾Ê´Â´Ù°í º¸°í ÀÖ´Ù. À¯ÀüÀÚ¿¡ ÀÇÇÑ ÀÌ»óÀ̳ª º´Àº Ãâ»ýÇÏ´Â ¾Æ±âÀÇ 1 %°¡ ÀÌ¹Ì °¡Áö°í Àְųª ¹ßº´ÇÒ °¡´É¼ºÀ» Áö´Ï°í ÀÖ´Ù. ¿°»öüÀÇ ±¸Á¶ ¶Ç´Â ±¸¼ºÀÇ ÀÌ»ó¿¡ ÀÇÇÏ¿© ÀϾ´Â ¿©·¯ °¡Áö ÀÌ»ó ´Ù¿î ÁõÈıº, ÅÍ³Ê ÁõÈıº, Ŭ¶óÀÎÆçÅÍ ÁõÈıº µîµµ ¿°»öü À§¿¡ À¯ÀüÀÚ°¡ ÀÖ´Ù°í ÇÏ´Â Àǹ̿¡¼­´Â À¯ÀüÇÐÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ±×·¯³ª ´ë°³´Â ÀÌ»ó °³Ã¼¸¦ ¸¸µç ¹è¿ìÀÚ
  • HIV associated periodontal disease
    HIV¿Í °ü·ÃµÈ Ä¡ÁÖ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
standards and guidelines Bounds or constraints within which all practices in a given area will be carried out, in achieving the goals and objectives for that area. Standards and guidelines provide environmental safeguards and also describe constraints prescribed by law.
(05 Dec 1998)
nebulisers and vaporisers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.
(12 Dec 1998)
state health planning and development agencies Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council.
(12 Dec 1998)
stem and loop structure <molecular biology> The structure of tRNAs is so termed because it has four base paired stems and three loops (not base paired), one of which contains the anticodon.
(18 Nov 1997)
neonatal diseases and abnormalities Diseases existing at birth and often before birth, regardless of causation. Of these congenital diseases, those characterised by structural deformities are termed abnormalities.
(12 Dec 1998)
neoplasms, adnexal and skin appendage Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.
(12 Dec 1998)
neoplasms, complex and mixed Neoplasms composed of more than one type of neoplastic tissue.
(12 Dec 1998)
neoplasms, connective and soft tissue Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.
(12 Dec 1998)
neoplasms, cystic, mucinous, and serous Neoplasms containing cyst-like formations or producing mucin or serum.
(12 Dec 1998)
neoplasms, ductal, lobular, and medullary Neoplasms, usually carcinoma, located within the centre of an organ or within small lobes, and in the case of the breast, intraductally. The emphasis of the name is on the location of the neoplastic tissue rather than on its histological type. most cancers of this type are located in the breast.
(12 Dec 1998)
neoplasms, germ cell and embryonal Neoplasms composed of primordial germ cells of embryonic gonads or of elements of the germ layers of the embryo. The concept does not refer to neoplasms located in the gonads or present in an embryo or foetus.
(12 Dec 1998)
neoplasms, glandular and epithelial Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.
(12 Dec 1998)
nephelometry and turbidimetry Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam.
(12 Dec 1998)
neuropathies, hereditary motor and sensory A group of slowly progressive inherited disorders in which the predominant involvement is the peripheral motor neurons with lesser involvement of the peripheral sensory neurons. Neuronal degeneration and atrophy are characteristic of these disorders. Some of the associated characteristics are phytanic acid excess, optic atrophy, and retinitis pigmentosa.
(12 Dec 1998)
neuropathies, hereditary sensory and autonomic A group of inherited disorders in which there is selective involvement of the peripheral sensory and autonomic neurons and degeneration of fibres by axonal atrophy and degeneration. Five types of disorders have been described and classified type I through type v.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
ÅëÇÕ°Ë»ö ¿Ï·á